Ken Griffin Neuro Pace Inc Call Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$6.65 - $8.46 $47,215 - $60,066
-7,100 Reduced 84.52%
1,300 $9,000
Q2 2024

Aug 14, 2024
BUY
$6.38 - $15.33 $21,692 - $52,122
3,400 Added 68.0%
8,400 $63,000
Q1 2024

May 15, 2024
BUY
$9.78 - $17.5 $48,900 - $87,500
5,000 New
5,000 $66,000

Others Institutions Holding NPCE

# of Institutions
52
Shares Held
21.3M
Call Options Held
1.3K
Put Options Held
100
View Full List

About NeuroPace Inc

NPCE Quotes by TradingView
  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $241M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email